Regeneron Pharmaceuticals Market Sentiment

Regeneron Pharmaceuticals Inc

REGNNASDAQ

$927.89

109.1213.33%

Ult. Agg.: Oct 30, 4:44 PM

Panoramica Notizie Previsioni utili Eventi Obiettivi di prezzo Dati finanziariSentimentAzionariato Dividendi Confronta Rapporto azionario

PRO

Perché si muove?:Regeneron Pharmaceuticals shares are trading higher after the company repor...

Utili: I risultati di Q3 2026 sono stati pubblicati in data ven ott 30th, prima dell'apertura del mercato

Conference call: La conference call più recente è iniziata alle 8:30 AM, 1 giorno fa

Clicca per vedere il webcast

Regeneron Pharmaceuticals Market Sentiment

Market sentiment signals for Regeneron Pharmaceuticals (REGN): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 2.2% short float

Options Flow— N/A

Insider Activity— Neutral (30d)

Analyst Consensus

Buy

29 analysts

Options Flow (P/C)

—

Avg Consensus PT

$834

-10.0%

Highest Price Target

$1050

+13.4%

JP Morgan

Lowest Price Target

$185

-80.0%

Benchmark

Short Interest

2.2%

Declining — Bullish

Insider Activity (30d)

Neutral

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 30, 2026	JP Morgan	Chris Schott—	+13.4%	$950 → $1050	Maintained	Overweight
Oct 30, 2026	Citigroup	Geoff Meacham—	-10.9%	$740 → $825	Maintained	Neutral
Oct 28, 2026	Canaccord Genuity	John Newman—	-0.4%	$875 → $922	Maintained	Buy
Oct 21, 2026	TD Cowen	Tyler Van Buren—	+5.8%	$960 → $980	Maintained	Buy
Oct 19, 2026	Piper Sandler	Biren Amin—	-6.6%	$854 → $865	Maintained	Overweight
Oct 15, 2026	UBS	Trung Huynh—	+5.6%	$660 → $978	Upgrade	Neutral→Buy
Oct 8, 2026	RBC Capital	Brian Abrahams—	-12.5%	$737 → $810	Maintained	Sector Perform
Oct 7, 2026	Truist Securities	Gregory Renza—	-15.8%	$772 → $780	Maintained	Buy
Oct 7, 2026	Morgan Stanley	Matthew Harrison—	-15.9%	$758 → $779	Maintained	Equal-Weight
Oct 6, 2026	JP Morgan	Chris Schott—	+2.6%	$900 → $950	Maintained	Overweight
Oct 1, 2026	Jefferies	Akash Tewari—	+0.4%	$870 → $930	Maintained	Buy
Oct 1, 2026	Argus Research	Jasper Hellweg—	-8.2%	$850	Upgrade	Hold→Buy
Sep 29, 2026	RBC Capital	Brian Abrahams—	-20.4%	$737 → $737	Maintained	Sector Perform
Sep 10, 2026	HSBC	Rajesh Kumar—	-0.6%	$800 → $920	Maintained	Buy
Aug 17, 2026	Leerink Partners	David Risinger—	-11.0%	$641 → $824	Maintained	Market Perform
Aug 3, 2026	Citigroup	Geoff Meacham—	-20.1%	$700 → $740	Maintained	Neutral
Aug 3, 2026	Guggenheim	Brad Canino—	+11.2%	$1000 → $1030	Maintained	Buy
Jul 31, 2026	RBC Capital	Brian Abrahams—	-20.4%	$696 → $737	Maintained	Sector Perform
Jul 31, 2026	Morgan Stanley	Matthew Harrison—	-18.1%	$730 → $758	Maintained	Equal-Weight
Jul 31, 2026	Cantor Fitzgerald	Carter Gould—	-14.1%	$750 → $795	Maintained	Overweight
Jul 31, 2026	Wells Fargo	Mohit Bansal—	-19.0%	$700 → $750	Maintained	Equal-Weight
Jul 31, 2026	Truist Securities	Gregory Renza—	-16.6%	$769 → $772	Maintained	Buy
Jul 21, 2026	Guggenheim	Brad Canino—	+8.0%	$995 → $1000	Maintained	Buy
Jul 9, 2026	Piper Sandler	Biren Amin—	-7.8%	$855 → $854	Maintained	Overweight
Jul 8, 2026	Morgan Stanley	Matthew Harrison—	-21.2%	$788 → $730	Maintained	Equal-Weight